Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 9/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | IL2 | P60568 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL420937 | 0.91 | MAPT (0.47) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29374383 | 0.89 | STAT3 (0.42) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29425802 | 0.83 | STAT3 (0.52) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29373472 | 0.80 | MAPT (0.49) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29426112 | 0.75 | MAPT (0.51) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29372634 | 0.70 | STAT3 (0.55) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL9057631 | 0.67 | ELANE (0.55) | STAT3MAPTMEN1KMT2APOLB | |
| Asperulosidic Acid SCHEMBL29459346 | 0.67 | MAPT (0.52) | STAT3MAPTMEN1KMT2APOLB | |
| Asperulosidic Acid SCHEMBL422107 | 0.67 | MAPT (0.52) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL31228857 | 0.66 | PTPN1 (0.59) | STAT3MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12465645-B2 | Anti-viral composition and method for preparing the same | REIF ALEXIA (US) | 2025-11-11 | — | — | US | claimed |
| US-20230310612-A1 | ANTI-VIRAL COMPOSITION AND METHOD FOR PREPARING THE SAME | REIF ALEXIA (US) | 2023-10-05 | — | — | US | claimed |
| US-12465645-B2 | Anti-viral composition and method for preparing the same | REIF ALEXIA (US) | 2025-11-11 | — | — | US | disclosed |
| US-20230310612-A1 | ANTI-VIRAL COMPOSITION AND METHOD FOR PREPARING THE SAME | REIF ALEXIA (US) | 2023-10-05 | — | — | US | disclosed |
| EP-3409766-B1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N ZYME BIOTEC GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |